Dogwood Therapeutics, Inc. (DWTX) vs Microbot Medical Inc. (MBOT)

A side-by-side comparison of Dogwood Therapeutics, Inc. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DWTX vs MBOT

growth of $100 · dividends reinvested · last 6y
DWTX -99.6% (-60.8%/yr)MBOT -85.1% (-27.2%/yr)MBOT compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120222023202420252026$0$15
DWTX MBOT

DWTX vs MBOT: by the numbers

  • •DWTX is the larger company ($53M vs $49M market cap).
  • •Both run net losses; DWTX's is the smaller (0.00% vs -4722.25% net margin).

Metrics side by side

Valuation

MetricDWTXMBOT
P/S ratioN/A142.97
P/B ratio0.780.72

Profitability

MetricDWTXMBOT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%-4722.25%
ROE-52.72%-23.70%
ROIC-38.04%-26.51%

Growth (annualized)

MetricDWTXMBOT
Total return CAGR (5Y)-58.44%-31.63%

Frequently asked

How have DWTX and MBOT total returns compared?
Over the past 5 years, DWTX delivered -58.44% and MBOT delivered -31.63% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.